Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.660
0.00 (0.00%)
Nov 21, 2024, 1:17 PM EST - Market open
Aerovate Therapeutics Market Cap
Aerovate Therapeutics has a market cap or net worth of $76.81 million as of November 21, 2024. Its market cap has decreased by -75.68% in one year.
Market Cap
76.81M
Enterprise Value
-11.38M
1-Year Change
-75.68%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since the IPO on June 30, 2021, Aerovate Therapeutics's market cap has decreased from $323.51M to $76.81M, a decrease of -76.26%. That is a compound annual growth rate of -34.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 77.09M | -87.69% |
| Dec 29, 2023 | 626.15M | -13.15% |
| Dec 30, 2022 | 720.93M | 150.50% |
| Dec 31, 2021 | 287.80M | -11.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 78.10M |
| I-Mab | 77.41M |
| P3 Health Partners | 77.30M |
| ESSA Pharma | 76.76M |
| Oncolytics Biotech | 76.26M |
| OptimizeRx | 75.89M |
| Armata Pharmaceuticals | 75.63M |
| Werewolf Therapeutics | 75.09M |